Quest Diagnostics Incorporated (DGX) Stock Grade

About Quest Diagnostics Incorporated's fundamentals

Quest Diagnostics is a major player in the medical diagnostics industry with a $19.3 billion market capitalization, currently trading at a P/E ratio of 19.4. The company demonstrated solid growth momentum with revenue increasing 11.8% year-over-year, while maintaining a net profit margin of 9.0%, indicating reasonable operational efficiency. With a return on equity of 13.8%, the company is generating moderate returns on shareholder capital, and it provides income to investors through a 1.9% dividend yield.